LSPedia is excited to introduce the new WEE Management Module as part of the upcoming OneScan 7.3 release on October 6, 2024. This innovative tool is designed to help trading partners efficiently manage Waiver, Exemption, and Exception (WEE) approvals, ensuring seamless operations and DSCSA compliance.
The WEE Management Module provides the crucial support you need to stay compliant. We're currently accepting 10 early adopters for the Beta Program, with waived license fees for 2024. Secure your spot today and stay ahead of the compliance deadline with LSPedia.
LSPedia has partnered with Pharma Logistics to enhance pharmaceutical supply chain efficiency and compliance. This collaboration integrates LSPedia’s OneScan solution, providing health systems and pharmacies with a comprehensive view of the supply chain, from manufacturing to end-of-life processing. The partnership aims to simplify DSCSA compliance, improve product traceability, and streamline operations, empowering customers to navigate the evolving regulatory landscape with greater confidence.
As the DSCSA Stabilization deadline approaches, ensuring compliance is more critical than ever. LSPedia’s Recall Management Module offers unmatched accuracy by delivering recall alerts only for products present at your locations, eliminating irrelevant notifications. With real-time FDA integration and direct connections to manufacturers, you can swiftly capture recalled products and maintain complete, compliant records.
Don’t risk falling behind with outdated data—our Recall Management system keeps you compliant and ready for inspections.
A major pharmaceutical wholesaler serving 8,000 customers faced a crisis in March 2024 when a DSCSA solution upgrade led to severe disruptions, halting shipments and threatening compliance. After a slow vendor response, they transitioned to LSPedia's OneScan suite. The new system went live ahead of schedule in July 2024, restoring stability, ensuring compliance, and improving efficiency, reinforcing their commitment to excellence.
DiversifyRx CEO Dr. Lisa Faast, LSPedia SVP of Sales and Marketing Daniel MacKinnon, and compliance expert Tish Pahl from Olsson Frank Weeda Terman Matz PC discuss why you should become compliant before the DSCSA stabilization period deadline on November 27, 2024.
Join us for an exclusive webinar hosted by LSPedia and RedSail Technologies. In this session, we'll cover:
What you need to do now to be compliant with the Drug Supply Chain Security Act (DSCSA) as the stabilization period deadline approaches.
Insights from LSPedia's DSCSA compliance experts on understanding and fulfilling your compliance responsibilities, regardless of eligibility for small dispenser exemptions.
The benefits of taking action today to maintain business with existing trading partners, manage liability, and ensure the safety and security of your patients post-deadline.
